Does vascular occlusion in liver resections predispose to recurrence of malignancy in the liver remnant due to ischemia/reperfusion injury? A comparative retrospective cohort study-Reference-Cited by-同舟云学术

Does vascular occlusion in liver resections predispose to recurrence of malignancy in the liver remnant due to ischemia/reperfusion injury? A comparative retrospective cohort study

Published:2020-08 Issue: Volume:80 Page:68-73
ISSN:1743-9191
Container-title:International Journal of Surgery
language:en
Short-container-title:International Journal of Surgery

Author:

Theodoraki Kassiani,Papadoliopoulou Maria,Petropoulou Zoe,Theodosopoulos Theodosios,Vassiliu Pantelis,Polydorou Andreas,Xanthakos Pantelis,Fragulidis George,Smyrniotis Vassilios,Arkadopoulos Nikolaos

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference32 articles.

1. Vascular control during hepatectomy: review of methods and results;Smyrniotis;World J. Surg.,2005

2. Selective hepatic vascular exclusion versus Pringle maneuver in major liver resections: prospective study;Smyrniotis;World J. Surg.,2003

3. Vascular occlusion to decrease blood loss during hepatic resection;Dixon;Am. J. Surg.,2005

4. Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection;Kusano;Eur. J. Surg. Oncol.,2009

5. Randomized clinical trial of hepatectomy using intermittent pedicle occlusion with ischaemic intervals of 15 versus 30 minutes;Esaki;Br. J. Surg.,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors of Positive Resection Margin in Hepatectomy for Resectable Ruptured Hepatocellular Carcinoma: Risk Prediction and Prognosis;Journal of Gastrointestinal Surgery;2023-04-24

2. The effect of the number of hepatic inflow occlusion times on the prognosis of ruptured hepatocellular carcinoma patients after hepatectomy;BMC Surgery;2022-03-13

3. Left Hepatectomy Through Double Approach and Total Vascular Exclusion for Giant Left Lobe Hepatocarcinoma;In Vivo;2021